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Epidemiological studies demonstrate a relationship betweenpathological events during foetal development and future cardiovascular risk and the
term ‘foetal programmingof cardiovascular disease’ has been coined todescribe this phenomenon. Theuseof assisted reproductive technologies
(ARTs) is growing exponentially and 2–5%of children are now born by this procedure. Emerging evidence indicates that ART represents a novel
important example of foetal programming. Assisted reproductive technology may modify the cardiovascular phenotype in two ways: (i) ART
involves manipulation of the early embryo which is exquisitely sensitive to environmental insults. In line with this concern, ART alters vascular
and cardiac function in children and studies in mice show that ART alters the cardiovascular phenotype by epigenetic alterations related to sub-
optimal culture conditions. (ii) Assisted reproductive technology markedly increases the risk of foetal insults that augment cardiovascular risk in
naturally conceived individuals and areexpected to have similar consequences in theARTpopulation.Given the young ageof theARTpopulation,
it will take another 20–30 years before data on cardiovascular endpoints will be available.What is clear already, however, is that ARTemerges as
an important cardiovascular risk factor. This insight requiresus to revisenotionsonART’s long-termsafety and toengageonadebateon its future.
There is an urgent need to better understand the mechanisms underpinning ART-induced alteration of the cardiovascular phenotype, improve
the procedure and its long-term safety, and, while awaiting this aim, not to abandonmedicine’s fundamental principle of doing no harm (to future
children) and use ART parsimoniously.
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Introduction
Based on epidemiological studies showing an association between
adverse events during early life and the prevalence of cardiovascular
disease later in life,1 Barker put forward the hypothesis of ‘foetal pro-
gramming of cardiovascular diseases’. These early epidemiological
studies focused on hard clinical cardiovascular endpoints. Progress in
the detection of early cardiovascular alterations known to increase
cardiovascular risk later in life,2,3 has opened up the possibility to
search for such alterations in young apparently healthy populations
at risk and design interventions to prevent premature cardiovascular
morbidityandmortality.This shiftof focus is illustratedbystudies inoff-
spring of mothers suffering from pre-eclampsia who are at increased
risk for stroke later in life4 and in whom alterations of the systemic
and pulmonary circulation are already detectable during childhood.5
Assisted reproductive technologies (ARTs) which initially were
developed to treat women with tubal disease, over the past decade
havebeenapplied toaneverexpanding listofother situations, resulting
in an exponential growth of the numberof babies bornby this proced-
ure who now account for 2–5% of births in developed countries.6
Based on emerging data showing that the early embryo is particularly
sensitive to environmental insults, we speculated that ART alters car-
diovascular function in theoffspring.Here,wesummarize this evidence
in animals and humans and explore how ART-induced epigenetic
alterations in the embryo and ART-related foetal insults may shape
cardiovascular function and determine future cardiovascular risk.
Assisted reproductive
technologies-induced cardiovascular
alterations in humans
Premature atherosclerosis
There is abundant evidence that in populations at risk for premature
cardiovascular morbidity and mortality, subclinical atherosclerosis is
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already detectable in childhood.3 Several non-invasive techniques
allow in populations at increased cardiovascular risk to detect
early, subclinical, vascular alterations, and predict outcome.2,7
Using such techniques, recent studies demonstrate that young appar-
ently healthy ART children display generalized endothelial dysfunc-
tion and exaggerated stiffening and morphological alterations of the
vasculature in the systemic circulation (Figure 1).8
Systemic endothelial dysfunction represents the first step in the
development of atherosclerosis and can be assessed by determining
the increaseof thebrachial arterydiameterevokedby reactivehyper-
aemia (flow-mediated vasodilation, FMD).2 Flow-mediated vasodila-
tion of the brachial artery is roughly 25% smaller in ART than in
control children.8 Endothelial dysfunction in ART children is not
limited to the systemic circulation, since high-altitude exposure
induces exaggerated hypoxic pulmonary hypertension in this popu-
lation. Moreover, systemic and pulmonary endothelial dysfunction
are correlated, indicating that endothelial dysfunction is a robust
finding in the ART population.8–11 Stiffening of the vasculature also
takes place during the early development of atherosclerosis and
has been shown to predict future cardiovascular risk in children
suffering fromdiseasesknowntopredispose toprematurecardiovas-
cular morbidity.3,12–14 Carotid-femoral pulse wave velocity, a proxy
of arterial stiffness, is significantly faster in ART children than in con-
trols.8 Finally, premature atherosclerosis in children is associated
with structural changes of the vasculature that can be assessed by
ultrasound measurement of the carotid intima-media thickness
(IMT).3,15–17 Carotid IMT is significantly increased in ART children.8
Structural changes of the vasculature in ART children appear to
develop very early, given that increased aortic IMT in utero has been
reported.18 In summary, these findings demonstrate vascular altera-
tions which suggest premature vascular ageing in young apparently
healthy ART children.
Arterial hypertension
Increased arterial blood pressure is expected to be one of the
first clinical consequences of ART-induced vascular dysfunction. In
line with this expectation, Ceelen and colleagues reported higher
systolic and diastolic office blood pressure in ART children than in
spontaneously conceived control children.19 Consistent with these
observations, preliminary data using 24-h ambulatory blood pressure
Figure 1 Assisted reproductive technology-induced cardiovascular alterations and consequences thereof in young apparently healthy children.
Assisted reproductive technology alters systemic and pulmonary vascular function. There is evidence that systemic vascular dysfunction translates
into increased arterial blood pressure and contributes to insulin resistance, whereas pulmonary vascular dysfunction predisposes to exaggerated
hypoxic pulmonary hypertension and right ventricular dysfunction. IMT, carotid intima-media thickness; PWV, pulse wave velocity; FMD, flow-
mediated dilation; PH, pulmonary hypertension; RV, right ventricle.
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measurements show that in ART children, vascular dysfunction is
associated with increased systolic and diastolic blood pressure com-
pared with control children.20 These differences in blood pressure
between ART and control children are clinically important, since
childhood blood pressure tracks into later life.21
Pulmonary hypertension
Pulmonary vascular dysfunction predisposes ART children to an
exaggerated increase of pulmonary artery pressure during acute
high-altitude exposure.8,9 This suggests that ART persons perman-
ently living at high altitude or suffering from diseases associated
with chronic hypoxaemia may be predisposed to pulmonary hyper-
tension. Moreover, exaggerated hypoxic pulmonary hypertension
is a risk factor for high-altitude pulmonary oedema,22,23 and ART
needs to be taken into account when giving advice for the prevention
of this problem.
Cardiac dysfunction and remodelling in utero that persist
into adolescence
There is evidence for foetal programming of cardiac function in
humans, as evidenced by remodelled and less efficient hearts in
children born after foetal growth restriction.24 In line with this
concept, cardiac remodelling and dysfunction has been reported
in ART comparedwith control fetuses.18 These problems persisted
in 6-month-old infants and predominated in the right heart.18
The recent observation of right ventricular dysfunction under
the stressful conditions of high-altitude exposure in ART adoles-
cents who were born at term with normal birth weight suggests
that cardiac alterations persist into adulthood.25 These findings
suggest that in addition to cause premature vascular ageing translat-
ing into increased arterial blood pressure, ART also alters cardiac
function.
Insulin resistance
Insulin stimulates blood flow and substrate delivery to the skeletal
muscles by an endothelium-dependent mechanism.26–28 Defective
nitric oxide-dependent insulin stimulation of blood flow and sub-
strate delivery to skeletal muscle tissue leads to insulin resistance in
experimental animal models and humans.27–29 In line with this
concept, a recent study demonstrated insulin resistance in young
adults conceived byART.30 These findings suggest that ART-induced
vascular dysfunction not only increases cardiovascular risk but may
also facilitate diabetes later in life.
An often overlooked issue, when discussing consequences of ART
oncardiovascular risk later in life, is thatARTnotonly induces cardio-
vascular dysfunction per se but also significantly increases the preva-
lence of pathological events during foetal life that markedly increase
cardiovascular risk in naturally conceived persons (Table 1).4,6,31–34
Assisted reproductive technology increases the risk of
pathological events during foetal life which are known to
increase cardiovascular risk in naturally conceived humans
Two examples serve to illustrate this problem. First, ART increases
the risk of the mother to suffer from pre-eclampsia. Pre-eclampsia
is known to induce generalized vascular dysfunction and hypoxic pul-
monary hypertension in the naturally conceived offspring that is de-
tectable already during childhood5 and known to more than double
the risk for stroke later in life.4 Secondly, ART markedly increases
the risk of premature birth.6,34 In naturally conceived young adults
bornpre-term, left ventricularmass, an independentpredictorof car-
diovascular morbidity and mortality,35 is increased.36 Interestingly,
it appears possible that perinatal interventions used to increase
pre-term perinatal survival may contribute to some of the observed
cardiovascular alterations.37 For example, antenatal glucocorticoid
administration to the mother to prevent respiratory distress in
the neonate and intravenous lipid infusions used for nutrition of
pre-term babies have been suggested to contribute to increased
aortic stiffness and cardiac dysfunction observed in young adulthood
in this population.37 Finally, it should be noted that inmany places, it is
still current practice to implantmore than one embryo at the time, in
order to increase the success rate of ART. This practice results in a
marked increase in the number ofmultiple pregnancies that are asso-
ciated with a further increase of the risk of pre-eclampsia, pre-term
birth, and lowbirthweight comparedwith singleton pregnancies.6 In-
triguingly, single embryo transfer with extended embryo culture,
another procedure used to increase the success rate of ART, also
increases the risk of pre-term birth.38
Collectively, these data indicate that even if ART would not cause
any cardiovascular alteration itself, by increasing the prevalence of
pathological foetal events known to increase cardiovascular risk
later in life, ART is expected to significantly increase premature car-
diovascular morbidity and mortality in the offspring.
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Table 1 Unfavourable perinatal outcomes in assisted reproductive technology children known to be associated with
increased cardiovascular risk in naturally conceived children
Perinatal outcomes in ART children Long-term outcomes in naturally conceived children
Arterial hypertension Ischaemic heart disease
Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
Pre-term birth (,37 weeks) 1.5 (1.5–1.6) 1.7 (1.3–2.2) 0.96 (0.80–1.16)
Low birth weight (,2500 g) 1.7 (1.6–1.8) 1.2 (1.1–1.3) 1.2 (0.88–1.44)
Small for gestational age 1.4 (1.3–2.1) — 1.6 (1.2–2.2)
ART, assisted reproductive technologies.
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Mechanisms underpinning assisted
reproductive technology-induced
cardiovascular dysfunction
Information from studies in assisted reproductive
technologies mice
Premature vascular aging, arterial hypertension, insulin resistance and
shortened life span in assisted reproductive technologies mice
Consistent with findings in humans, endothelium-dependentmesen-
teric artery dilation is defective and carotid artery stiffness and arter-
ial blood pressure are increased inARTmice.39Moreover, ARTmice
display insulin resistance.30 These data in normal mice further dem-
onstrate the potential of ART to alter the cardiovascular and meta-
bolic phenotype and strengthen the concept that these problems
are related to ART per se. Moreover, and of potential importance
for the long-term outcome of the ART population in humans,
ART has consequences on the life span; when challenged with a
Western style high-fat diet, the life span of ARTmice was shortened
by roughly 25% compared with control mice. Assisted reproductive
technologies mice also provide unique insight into mechanisms
underpinning ART-induced cardiovascular dysfunction.
Inhumans, it isdifficult todefinitivelyexclude thepossibility thatpar-
ental factors (i.e. older age of parents necessitating to resort to ART,
transmission by ART of sterility-associated vascular dysfunction to
theoffspring) contribute to alterationof the cardiovascular phenotype
in the ART population. The finding that in normal mice, ART induces
premature vascular aging and arterial hypertension, strongly supports
the contention that ART itself is an important factor in the program-
ming of offspring cardiovascular dysfunction but it does not exclude
the possibility that other mechanismsmay also play a part, particularly
in humans. The findings inmice also suggest that hormonal stimulation
of the ovulation in the mother is not an important determinant of
ART-induced vascular dysfunction.39
Role of epigenetic mechanisms underpinning cardiovascular dysfunction
There is increasing data indicating that epigeneticmechanisms play an
important role in the foetal programming of phenotypic alterations
that may determine the risk of adult diseases.40,41 The term ‘epigen-
etic’ refers to changesof geneexpression that arenot related tomod-
ifications of the DNA sequence, but to altered methylation of
cytosine residues, chromatin structure, or histone acetylation
which modify the availability of DNA for transcription. During gam-
etogenesis, fertilization, and early embryo development, the epigen-
ome undergoes a series of changes,41 suggesting that these stages are
particularly vulnerable to epigenetic dysregulation. In line with this
speculation, the methylation of the insulin-like growth factor-2
gene is altered in offspring of parents exposed periconceptually to
famine,42 and the frequency of rare imprinting disorders associated
with epigenetic dysregulation is higher-than-expected in ART chil-
dren.40,43 This suggests that epigenetic mechanisms may underpin
ART-induced cardiovascular dysfunction. Studies in ART mice
provide direct support for this hypothesis.
Epigenetic alterations are maintained during cell division may
persist throughout the life span of the individual41,44,45 and some-
times be transmitted to the next generation.46 Consistent with this
concept, vascular dysfunction in the progeny of male ART mice
mated with normal females is comparable with the one observed in
the fathers and is associated with similar alterations of the methyla-
tion of genes in the vasculature.39 More specifically, in ART mice
the methylation of the promoter of the gene coding for endothelial
nitric oxide synthase (eNOS) is altered in the aorta. This dysmethyla-
tion has important consequences, because it is associated with
decreased eNOS expression, decreased eNOS mRNA expression,
and lower nitric oxide plasma concentration in ART than in control
mice.39 Of note, the methylation of the endothelin-1 and the ACE
gene is not altered in ART mice, indicating that ART does not
induce global changes of DNA methylation of genes involved in
vascular regulation.39
Histone deacetylase-inhibitors have been shown to reverse epi-
genetic and phenotypic changes induced by pathologic events
during early life and to prevent transmission of these changes to
the progeny.39,47 Consistent with these observations, butyrate ad-
ministration to adult male ART mice normalizes the methylation
andexpressionof theeNOSgene in vascular tissue togetherwith vas-
cular responsiveness to acetylcholine and prevents the transmission
of these alterations to the progeny.39,47
Collectively, these findings indicate that in mice, ART alters
the cardiovascular phenotype by an epigenetic mechanism which
changes theentirechainof events starting fromalteredeNOSmethy-
lation in the vasculature over endothelial dysfunction and premature
vascular senescence to arterial hypertension and possibly premature
mortality.39
Studies inmice also providemechanistic information that could be
important for ART in humans. Culture time may be a determinant
of ART-induced epigenetic and cardiovascular alterations. In mice,
endothelial dysfunction and arterial hypertension are comparable
inARTmice generated by implantationof two-cell embryos andblas-
tocysts, suggesting that the timeneeded toobtain two-cell embryos is
sufficient to cause these changes.39 In keeping with this observation,
alteredmethylation patterns and geneexpression are alreadydetect-
able in two-cell embryos.48 In humans, embryos are generally
implanted at the blastocyst stage. The findings in mice suggest that
in humans shortening the time lag between fertilization and implant-
ation is unlikely to prevent ART-induced vascular dysfunction.
Current culture media used for ART are suboptimal, as shown by
reduced pregnancy rates, viability, and growth of cultured compared
with in vivo embryos.39Culturemediamay lack, or contain at different
concentration, keymetabolites and/or growth factors present in ovi-
ductal fluid and are not capable of reproducing the dynamic changes
of oviductal fluid naturally occurring along the female reproductive
tract. In line with this concept, suboptimal culture conditions in vitro
compromise the abilityof theembryo tomaintain genetic imprinting.48
Taken together, these findings suggest that suboptimal culture condi-
tions contribute to ART-induced cardiovascular dysfunction.
Information from studies in humans
While mechanistic studies are difficult to perform in young appar-
ently healthy children, these studies nevertheless provide some
information on potential underlying mechanisms. Vascular dysfunc-
tion does not appear to depend on the technique used for ART,
because it is similar in children born after in vitro fertilization and
intra-cytoplasmic sperm injection and in children born after the
transfer of frozen zygotes or the transfer of fresh embryos.8 Assisted
reproductive technology-induced cardiovascular dysfunction is also
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notdependent upon thepresenceof lowbirthweightorprematurity,
since it occurs in children born with normal birth weight and at
term.8,25 Parent-related factors, such as increased prevalence of car-
diometabolic disease in sterile parents, maternal age, or hormonal
stimulation of the ovulation, do not appear to play a role.8 Sterility
in the parents is not associated with vascular dysfunction that could
be transmitted to the offspring by ART.8 Finally, some49 but not
other studies50 have suggested that parental psychological stress
during pregnancy alters the cardiovascular phenotype in the off-
spring. To the best of our knowledge, this potential mechanism has
not been investigated in ART. Collectively, these observations
suggest that parent-related factors do not play an important role
and that vascular dysfunction in offspringofART is related to the pro-
cedure itself. Interestingly, an impairment of endothelial functionwas
foundnotonly inARTchildrenbut also in offspringofmothers suffer-
ing from pre-eclampsia,5,7 suggesting that pathological events occur-
ring during embryonic and late foetal life have similar long-term
consequences for the circulation.7
How to avoid assisted reproductive
technologies-induced cardiovascular
dysfunction in the future and how to
prevent the long-term consequences of
this problem in those already born
Figure 2 depicts possibilities for interventions thatmay allowattaining
this aim. First, studies inmice show thatmodification of culturemedia
may attenuate ART-induced epigenetic and cardiovascular altera-
tions.39 This observation suggests that some culture conditions
could be less detrimental for the offspring than others. In this
context, it is very surprising that there exists no information on the
exact composition of culture media used for ART and no detailed in-
formation on the ART-procedures used in fertility clinics. There is an
urgent need tooblige suppliers and clinics to provide this information
in order to identify procedures thatmay have less detrimental effects
on cardiovascular function and long-term health in the offspring than
others. The identification of best practice of ART will also need
Figure 2 Mechanisms underpinning assisted reproductive technology-induced alteration of the cardiovascular phenotype and possibilities for
prevention and/or intervention. Assisted reproductive technology alters the cardiovascular phenotype and increases cardiovascular risk in two
ways. (i) Suboptimal culture conditions cause epigenetic changes in the embryo that result in an altered cardiovascular phenotype.41 Improve-
ment/modification of culture conditions may attenuate assisted reproductive technology-induced epigenetic alterations and administration of
drugs that restore epigenetic changes reinstate a normal cardiovascular phenotype.39 (ii) Assisted reproductive technology increases the prevalence
of pathological events during the foetal period which are known to increase cardiovascular morbidity and mortality in naturally conceived
persons.6,34 Single embryo transfer is expected to eliminate the additional risk of foetal insults related to multiparity,6,34 implantation of 3-day
embryos appears tobe associatedwith a lower riskof foetal insults thanblastocyst transfer.6 Finally, pharmacological interventions aimedat restoring
a normal cardiovascular phenotype are expected to decrease ART-related cardiovascular risk in the offspring.9
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long-term studies on outcome in the ART population. Surprisingly,
funding bodies appear to have little interest in financing such
studies. The reason(s) for this reluctance are not clear, but the enor-
mous financial interests related to ART, the apparently healthy
looking aspect of this young ART population, and considerations
related to political correctness, to name just a few, may play a role.
Second, studies inARTmice show that administrationof drugs that
normalize altered methylation of genes implicated in cardiovascular
regulation normalizes cardiovascular function, suggesting that inter-
ventions aimed at normalizing epigenetic alterations may decrease
long-term cardiovascular risk in the ART population and prevent
potential transmission of this risk to the progeny.39
Thirdly, single embryo transfer is expected to eliminate the add-
itional augmentation of cardiovascular risk related to the increased
prevalence of prematurity, low birth weight and pre-eclampsia asso-
ciated with multiple gestation.6
Fourthly, early detection of altered cardiovascular function and
cardiovascular risk factors in the ART population is expected
to allow for timely intervention to prevent/postpone premature
cardiovascular disease. For example, recent observations in children
suggest that ART-induced vascular dysfunction is related to altered
redox regulation and reversible.9 In this regard, medical history
taking needs to include questioning about mode of conception and
foetal/perinatal complications, as more aggressive reduction of
other, modifiable cardiovascular risk factors may be needed among
some of these populations.
Conclusions and future
perspectives
Many questions remain open regarding the exact underlying mechan-
isms involved in ART-induced alterations of cardiovascular function
and its long-term consequences. What is already clear, however, is
thatARTemerges as amajor novel cardiovascular risk factorexpected
tobe present in 2–5%of the population in industrialized countries and
with the potential to be transmitted to future generations.
Assisted reproductive technology alters cardiovascular function
and increases cardiovascular risk in two ways. First, ART alters the
cardiovascular phenotype by epigenetic changes that are induced
during a period encompassing harvesting of oocytes and sperm,
in vitro fertilization and embryo culture. Second, ART markedly
increases the prevalence of prematurity, low birth weight and pre-
eclampsia, perinatal conditions known to increase cardiovascular
morbidity and mortality in naturally conceived humans. A major
problemat this time is that given theyoungageof theARTpopulation,
we will not know before 20–30 years from now the exact conse-
quences of ART-induced premature atherosclerosis on cardiovascu-
lar endpoints (arterial hypertension, stroke, myocardial infarction,
hypoxic pulmonary hypertension, and relatedmorbidity andmortal-
ity). Extrapolation from young populations with a similar risk profile
and known prevalence of cardiovascular morbidity and mortality
later in life suggest that they may be important.7
Key questions to be resolved are, what detrimental events at spe-
cific stages of the in vitro development induce epigenetic alterations
that lead to cardiovascular dysfunction, what are the underlying
mechanisms, andwhat are themeans thatmayallow these alterations
to be prevented/restored. What are the mechanisms by which ART
facilitates pathological events during foetal life that increase the risk
for cardiovascular disease in the offspring, and are there ways to
prevent these events? Are there ART procedures that have less det-
rimental long-term cardiovascular effects than others? To attain
these aims, there is an urgent need to oblige providers to fully docu-
mentARTprocedures and to initiate long-term studies on cardiovas-
cular outcome. Last but not least, it should be noted here that ART
represents a uniqueopportunity to studyeffects, underlyingmechan-
isms and possibilities for prevention/reversal of epigenetically
induced alterations of the phenotype that are expected to be of
importance beyond the field of ART.
Assisted reproductive technology emerges as an important risk
factor for long-term health with potentially major socio-economic
consequences. Society and politics need to engage in a debate on
the future of ART and the consequences of its exponential growth
for public health. Profit-driven initiatives to promote social freezing
in presumably fertile young women appear hardly defendable at
this time, as is medicine’s deliberate abandon of its fundamental prin-
ciple of doing no harm (to future children). What is needed now is
tounderstand themechanismsunderpinningART-inducedalteration
of the cardiovascular phenotype, improve the procedure, and
establish its long-term safety, and, while awaiting the results, use
ART parsimoniously.
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